Synthesis, Radiosynthesis, and in vitro Studies on Novel Hypoxia PET Tracers Incorporating [18F]FDR

被引:1
作者
Musolino, Manuele [1 ,2 ]
Fleming, Ian N. [1 ,2 ]
Schweiger, Lutz F. [1 ,2 ]
O'Hagan, David [3 ,4 ]
Dall'Angelo, Sergio [1 ,2 ]
Zanda, Matteo [1 ,2 ,5 ]
机构
[1] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland
[2] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen AB25 2ZD, Scotland
[3] Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland
[4] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland
[5] Ist Sci & Tecnol Chim G Natta SCITEC, Via Mancinelli 7, I-20131 Milan, Italy
基金
英国工程与自然科学研究理事会;
关键词
FDR; Hypoxia; Positron emission; Radiochemistry; Tomography;
D O I
10.1002/ejoc.202001670
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
We report the synthesis of five radiotracers incorporating different oxyamine spacers between the hypoxia-reactive 2-nitroimidazole moiety and the 5-[F-18]-fluorodeoxyribose ([F-18]FDR, 12) prosthetic group: three linear alkyl chains with 3, 5, 7 carbon atoms (15 a-c), a cyclopropyl ring (15 d) and a 1,4-disubstituted-1,2,3-triazole (15 e). Experiments in hypoxic cells showed that 15 d displays superior uptake kinetics - and similar selectivity for hypoxic cells - relative to the gold standard hypoxia tracers [F-18]fluoroazomycin arabinoside ([F-18]FAZA) and [F-18]fluoromisonidazole ([F-18]FMISO). Lipophilicity and structural rigidity have strong influence on the selectivity of tracers 15 towards hypoxic cells: the lead tracer 15 d displays a logP=0.38 and the most rigid spacer. A sixth radiotracer (15 f), with a 2-H-imidazole replacing the 2-nitroimidazole moiety of 15 d, was used to demonstrate that the cyclopropyl group does not play a meaningful role in the sensitivity towards hypoxia.
引用
收藏
页码:1429 / 1439
页数:11
相关论文
共 37 条
[11]   Chemistry for Positron Emission Tomography: Recent Advances in 11C-, 18F-, 13N-, and 15O-Labeling Reactions [J].
Deng, Xiaoyun ;
Rong, Jian ;
Wang, Lu ;
Vasdev, Neil ;
Zhang, Lei ;
Josephson, Lee ;
Liang, Steven H. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2019, 58 (09) :2580-2605
[12]   Imaging tumour hypoxia with positron emission tomography [J].
Fleming, I. N. ;
Manavaki, R. ;
Blower, P. J. ;
West, C. ;
Williams, K. J. ;
Harris, A. L. ;
Domarkas, J. ;
Lord, S. ;
Baldry, C. ;
Gilbert, F. J. .
BRITISH JOURNAL OF CANCER, 2015, 112 (02) :238-250
[13]   How Can We Overcome Tumor Hypoxia in Radiation Therapy? [J].
Harada, Hiroshi .
JOURNAL OF RADIATION RESEARCH, 2011, 52 (05) :545-556
[14]  
Haubner R., 2014, BIOMED RES INT, V2014, P1, DOI DOI 10.1155/2014/243185
[15]   15N-D-labeled ionic probes for mass spectrometry [J].
Ito, Fumihiro ;
Ando, Shin ;
Iuchi, Masato ;
Ukari, Taki ;
Takasaki, Momoka ;
Yamaguchi, Kentaro .
TETRAHEDRON, 2011, 67 (41) :8009-8013
[16]   Hypoxia-inducible factor-1 (HIF-1) [J].
Ke, Qingdong ;
Costa, Max .
MOLECULAR PHARMACOLOGY, 2006, 70 (05) :1469-1480
[17]   Efficient cartridge purification for producing high molar activity [18F]fluoro-glycoconjugates via oxime formation [J].
Keinanen, Outi ;
Partelova, Denisa ;
Alanen, Osku ;
Antopolsky, Maxim ;
Sarparanta, Mirkka ;
Airaksinen, Anu J. .
NUCLEAR MEDICINE AND BIOLOGY, 2018, 67 :27-35
[18]   Molecular Imaging of Tumor Hypoxia with Positron Emission Tomography [J].
Kelada, Olivia J. ;
Carlson, David J. .
RADIATION RESEARCH, 2014, 181 (04) :335-349
[19]   Molecular imaging of hypoxia [J].
Krohn, Kenneth A. ;
Link, Jeanne M. ;
Mason, Ralph P. .
JOURNAL OF NUCLEAR MEDICINE, 2008, 49 :129S-148S
[20]  
Kumar P, 1999, J LABELLED COMPD RAD, V42, P3, DOI 10.1002/(SICI)1099-1344(199901)42:1<3::AID-JLCR160>3.3.CO